Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.

Ian J Majewski, Lorenza Mittempergher, Nadia M Davidson, Astrid Bosma, Stefan M Willems, Hugo M Horlings, Iris de Rink, Liliana Greger, Gerrit KJ Hooijer, Dennis Peters, Petra M Nederlof, Ingrid Hofland, Jeroen de Jong, Jelle Wesseling, Roelof JC Kluin, Wim Brugman, Ron Kerkhoven, Frank Nieboer, Paul Roepman, Annegien Broeks, Thomas R Muley, Jacek Jassem, Jacek Niklinski, Nico van Zandwijk, Alvis Brazma, Alicia Oshlack, Michel van den Heuvel, René Bernards, Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing. The Journal of Pathology. ,vol. 230, pp. 270- 276 ,(2013) , 10.1002/PATH.4209

Sara A Byron, Huaibin Chen, Andreas Wortmann, David Loch, Michael G Gartside, Farhad Dehkhoda, Steven P Blais, Thomas A Neubert, Moosa Mohammadi, Pamela M Pollock, The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors. Neoplasia. ,vol. 15, pp. 975- 988 ,(2013) , 10.1593/NEO.121106

Masaru Katoh, Hitoshi Nakagama, FGF receptors: cancer biology and therapeutics. Medicinal Research Reviews. ,vol. 34, pp. 280- 300 ,(2014) , 10.1002/MED.21288

Wenjun Zhou, Wooyoung Hur, Ultan McDermott, Amit Dutt, Wa Xian, Scott B. Ficarro, Jianming Zhang, Sreenath V. Sharma, Joan Brugge, Matthew Meyerson, Jeffrey Settleman, Nathanael S. Gray, A Structure-Guided Approach to Creating Covalent FGFR Inhibitors Chemistry & Biology. ,vol. 17, pp. 285- 295 ,(2010) , 10.1016/J.CHEMBIOL.2010.02.007

W Blot, Q Cai, A H Wu, C-C Tseng, D Van Den Berg, D O Stram, A Cox, I W Brock, M W R Reed, K Muir, A Lophatananon, S Stewart-Brown, P Siriwanarangsan, W Zheng, S Deming-Halverson, M J Shrubsole, J Long, X-O Shu, W Lu, Y-T Gao, B Zhang, P Radice, P Peterlongo, S Manoukian, F Mariette, S Sangrajrang, J McKay, F J Couch, A E Toland, D Yannoukakos, O Fletcher, N Johnson, I dos Santos Silva, J Peto, F Marme, B Burwinkel, P Guénel, T Truong, M Sanchez, C Mulot, S E Bojesen, B G Nordestgaard, H Flyer, H Brenner, A K Dieffenbach, V Arndt, C Stegmaier, A Mannermaa, V Kataja, V-M Kosma, J M Hartikainen, D Lambrechts, B T Yesilyurt, G Floris, K Leunen, J Chang-Claude, A Rudolph, P Seibold, D Flesch-Janys, X Wang, J E Olson, C Vachon, K Purrington, G G Giles, G Severi, L Baglietto, C A Haiman, B E Henderson, F Schumacher, L Le Marchand, J Simard, M Dumont, M S Goldberg, F Labrèche, R Winqvist, K Pylkäs, A Jukkola-Vuorinen, M Grip, P Devilee, R A E M Tollenaar, C Seynaeve, M García-Closas, S J Chanock, J Lissowska, J D Figueroa, K Czene, M Eriksson, K Humphreys, H Darabi, M J Hooning, M Kriege, J M Collée, M Tilanus-Linthorst, J Li, A Jakubowska, J Lubinski, K Jaworska-Bieniek, K Durda, H Nevanlinna, T A Muranen, K Aittomäki, C Blomqvist, N Bogdanova, T Dörk, P Hall, G Chenevix-Trench, D F Easton, P D P Pharoah, J I Arias-Perez, P Zamora, J Benítez, R L Milne, , , , D Agarwal, , S Pineda, K Michailidou, J Herranz, G Pita, L T Moreno, M R Alonso, J Dennis, Q Wang, M K Bolla, K B Meyer, P Menéndez-Rodríguez, D Hardisson, M Mendiola, A González-Neira, A Lindblom, S Margolin, A Swerdlow, A Ashworth, N Orr, M Jones, K Matsuo, H Ito, H Iwata, N Kondo, M Hartman, M Hui, W Y Lim, P T-C Iau, E Sawyer, I Tomlinson, M Kerin, N Miller, D Kang, J-Y Choi, S K Park, D-Y Noh, J L Hopper, D F Schmidt, E Makalic, M C Southey, S H Teo, C H Yip, K Sivanandan, W-T Tay, H Brauch, T Brüning, U Hamann, A M Dunning, M Shah, I L Andrulis, J A Knight, G Glendon, S Tchatchou, M K Schmidt, A Broeks, E H Rosenberg, L J van't Veer, P A Fasching, S P Renner, A B Ekici, M W Beckmann, C-Y Shen, C-N Hsiung, J-C Yu, M-F Hou, FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium British Journal of Cancer. ,vol. 110, pp. 1088- 1100 ,(2014) , 10.1038/BJC.2013.769

Ariane Jansma, Qiong Zhang, Bing Li, Qiang Ding, Tetsuo Uno, Badry Bursulaya, Yi Liu, Pascal Furet, Nathanael S. Gray, Bernhard H. Geierstanger, Verification of a designed intramolecular hydrogen bond in a drug scaffold by nuclear magnetic resonance spectroscopy. Journal of Medicinal Chemistry. ,vol. 50, pp. 5875- 5877 ,(2007) , 10.1021/JM700983A

Fumiaki Ito, None, Foreword. Target therapy for cancer: anti-cancer drugs targeting growth-factor signaling molecules. Biological & Pharmaceutical Bulletin. ,vol. 34, pp. 1773- 1773 ,(2011) , 10.1248/BPB.34.1773

Alberto Peláez-García, Rodrigo Barderas, Sofía Torres, Pablo Hernández-Varas, Joaquín Teixidó, Félix Bonilla, Antonio Garcia de Herreros, J. Ignacio Casal, FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0063695

Nobuyuki Itoh, The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biological & Pharmaceutical Bulletin. ,vol. 30, pp. 1819- 1825 ,(2007) , 10.1248/BPB.30.1819

Amy L.S. Tai, Jonathan S.T. Sham, Dan Xie, Yan Fang, Yi-Long Wu, Liang Hu, Wen Deng, George S.W. Tsao, Gui-Bin Qiao, Annie L.M. Cheung, Xin-Yuan Guan, Co-overexpression of Fibroblast Growth Factor 3 and Epidermal Growth Factor Receptor is correlated with the development of nonsmall cell lung carcinoma Cancer. ,vol. 106, pp. 146- 155 ,(2006) , 10.1002/CNCR.21581